cbdMD (AMEX:YCBD) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.05) by 60 percent. This is a 95.79 percent increase over losses of $(1.90) per share from the same period last year. The company reported quarterly sales of $5.640 million which beat the analyst consensus estimate of $5.292 million by 6.58 percent. This is a 17.50 percent increase over sales of $4.800 million the same period last year.